Clinical Trial Update: Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating ADG126 in combination with pembrolizumab for locally advanced colorectal cancer is currently recruiting. The study is led…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ADG126
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Locally Advanced Colorectal Cancer | Phase 2 | Status: RECRUITING